Published in Clin Exp Immunol on April 01, 1970
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest (1999) 3.00
Practolol-induced drug eruption. Proc R Soc Med (1973) 2.62
The immune response to thetaX 174 in man. I. Primary and secondary antibody production in normal adults. Clin Exp Immunol (1973) 2.10
Cell-mediated immunity and lymphocyte transformation in syphilis. Proc R Soc Med (1971) 1.48
Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. J Clin Invest (1983) 1.43
Distinctive development of IgG4 subclass antibodies in the primary and secondary responses to keyhole limpet haemocyanin in man. Immunology (1990) 1.18
The human secondary immune response to Keyhole limpet haemocyanin. Clin Exp Immunol (1972) 1.15
In vitro lymphocyte responses and skin test reactivity following BCG vaccination. Clin Exp Immunol (1971) 1.13
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine. Clin Exp Immunol (1986) 1.01
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine. Immunology (2009) 0.99
Immunologic specificity of transfer factor. J Clin Invest (1974) 0.98
Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigens. Can Med Assoc J (1975) 0.98
Analysis of human anti-diphtheria antibodies by isoelectric focusing: evidence for restricted clonal heterogeneity of anti-fragment A antibodies. Infect Immun (1981) 0.93
The primary immune response to haemocyanin in patients with primary biliary cirrhosis. Clin Exp Immunol (1973) 0.92
Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin. Can Med Assoc J (1971) 0.86
Factors influencing the secondary antibody response to flagellin in man. Clin Exp Immunol (1978) 0.85
Basophils in tuberculin and "Jones-Mote" delayed reactions of humans. J Clin Invest (1976) 0.85
Lymphocyte transformation with thyroglobulin in thyroid diseases. Clin Exp Immunol (1972) 0.83
Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation. Clin Exp Immunol (1976) 0.83
Blastogenic suppression and alloantibody activity of sera from renal allograft recipients. J Clin Invest (1974) 0.81
Normal human IgG with antibody activity for keyhole limpet haemocyanin. Immunology (1973) 0.80
Cells binding the antigen keyhole limpet haemocyanin in the peripheral blood and in the lymphocyte cultures of non-immune and immunized human subjects. Clin Exp Immunol (1974) 0.80
Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies. Br J Clin Pharmacol (2014) 0.78
Studies of migration inhibition tests in penicillin hypersensitivity. Clin Exp Immunol (1979) 0.78
Proliferation assay amplification by IL-2 in model primary and recall antigen systems. BMC Res Notes (2014) 0.77
Stimulation of lymphocytes by antigen in microplate cultures; absence of an effect of transfer factor in vitro. Clin Exp Immunol (1976) 0.75
Cell populations in leucocyte adherence inhibition: requirement for T lymphocytes with IgG Fc receptors. Immunology (1982) 0.75
Dissociation of human serum macroglobulins. Science (1957) 10.94
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81
The specificity of allergic reactions. I. Delayed versus Arthus hypersensitivity. J Exp Med (1960) 5.00
Studies on hypersensitivity. III. The relation between delayed reactivity to the picryl group of conjugates and contact sensitivity. Immunology (1959) 4.88
The carriage of immunological memory by small lymphocytes in the rat. J Exp Med (1966) 4.73
THE HETEROGENEITY OF THE IMMUNE RESPONSE. Science (1964) 3.71
Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med (1965) 3.54
The effect of passively administered antibody on antibody synthesis. J Exp Med (1967) 3.31
Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med (1967) 3.29
Studies on hypersensitivity. IV. The relationship between contact and delayed sensitivity: a study of the specificity of cellular immune reactions. J Exp Med (1961) 3.07
IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES. Lancet (1964) 2.86
Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57
A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas. J Immunol (1962) 2.27
Immunochemical studies on the antigenic determinants required to elicit delayed and immediate hypersensitivity reactions. J Exp Med (1966) 2.03
The effect of phytohaemagglutinin and other lymphocyte mitogens on immunoglobulin synthesis by human peripheral blood lymphocytes in vitro. Clin Exp Immunol (1968) 1.97
The antibody responses of rabbits and rats to hemocyanin. J Immunol (1966) 1.75
Studies on Vi antigen. VI. Immunization of human beings with purified Vi antigen. Am J Hyg (1954) 1.64
Diagnostic and prognostic significance of the quantitative tuberculin tests. The influence of subclinical infections with atypical mycobacteria. Ann Intern Med (1967) 1.54
SPECIFIC AND NON-SPECIFIC STIMULATION OF ANTIBODY SYNTHESIS BY HUMAN LEUCOCYTES IN VITRO. Lancet (1965) 1.47
Antigenicity of polypeptides (poly alpha amino acids). VII. Studies in humans. J Exp Med (1962) 1.40
THE EFFECT OF 6-MERCAPTOPURINE ON IMMUNE RESPONSE IN MAN. N Engl J Med (1964) 1.35
Immunologic studies with ethylene oxide-treated human serum. J Exp Med (1961) 1.28
The effect of skin homograft rejection on recipient and donor mixed leukocyte cultures. J Exp Med (1965) 1.22
Correlation of tuberculin skin reaction with in vitro lymphocyte transformation. Am Rev Respir Dis (1968) 1.18
Studies on the in vitro behavior of agammaglobulinemic lymphocytes. J Clin Invest (1968) 1.17
Studies on the antibody response in splenectomized persons. N Engl J Med (1959) 1.16
Transfer of allergic contact-type delayed sensitivity in man. J Invest Dermatol (1957) 1.10
Some immunochemical differences between associated and dissociated hemocyanin. Arch Biochem Biophys (1959) 1.09
Comparison of lymphocyte transformation and intradermal reactions to tuberculins. Am Rev Respir Dis (1966) 1.08
Impaired delayed hypersensitivity in an aging population. Association with antinuclear reactivity and rheumatoid factor. JAMA (1968) 1.07
IMMUNOCHEMICAL STUDIES OF HEMOCYANIN FROM THE GIANT KEYHOLE LIMPET (MEGATHURA CRENULATA) AND THE HORSESHOE CRAB (LIMULUS POLYHEMUS). J Immunol (1965) 0.98
Development of immunological memory during the primary immune response. Nature (1967) 0.95
Antibody synthesis by transformed cells in rabbit lymphocyte cultures. Development of plaque-forming cells and liberation of agglutinating antibodies in antigen-stimulated cultures. Scand J Haematol (1968) 0.81
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep (1966) 8.79
A new type of synthetic peptide library for identifying ligand-binding activity. Nature (1991) 7.81
Contributions to the Biochemistry of Pathogenic Anaerobes. III. The effect of Acids on the Growth of Bacillus Welchii (B. perfringens) and Bacillus sporogenes (Metchnikoff). Biochem J (1917) 7.56
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med (1966) 7.30
Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes. J Immunol (1968) 4.25
The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol (1968) 4.24
Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. J Natl Cancer Inst (1983) 4.14
Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science (1987) 4.02
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis (1983) 3.86
Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med (1965) 3.54
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol (2000) 3.50
Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol (2001) 3.38
Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res (2000) 3.03
Emil J Freireich: a pioneer of modern oncology (interview by Sue Silver). Lancet Oncol (2001) 3.02
Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer (2000) 2.87
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
Flow cytometry in clinical cancer research. Cancer Res (1983) 2.72
Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults. Cancer Chemother Rep (1972) 2.71
Impact of the Massachusetts tobacco control programme: population based trend analysis. BMJ (2000) 2.67
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis (1985) 2.64
The nature and control of infections in patients with acute leukemia. Cancer Res (1965) 2.55
Comparison of touch imprints with aspirate smears for evaluating bone marrow specimens. Am J Clin Pathol (1999) 2.38
Erythropietic colonies in cultures of human marrow. Blood (1974) 2.24
Reasons for quitting: intrinsic and extrinsic motivation for smoking cessation in a population-based sample of smokers. Addict Behav (1998) 2.10
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med (1993) 2.09
Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod (1997) 1.92
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
A comprehensive compilation and alignment of histones and histone genes. Nucleic Acids Res (1989) 1.91
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood (1998) 1.91
A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. J Consult Clin Psychol (1995) 1.88
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
Lineage infidelity in acute leukemia. Blood (1983) 1.74
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology (1991) 1.67
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst (1995) 1.67
Non-randomized controls in cancer clinical trials. N Engl J Med (1974) 1.67
Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis (1984) 1.67
Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet (1973) 1.66
Causes of death in adults with acute leukemia. Medicine (Baltimore) (1976) 1.65
Cellular DNA content as a marker of neoplasia in man. Am J Med (1980) 1.62
Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer (1988) 1.62
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med (1973) 1.57
Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med (1984) 1.57
Cancer immunotherapy. Can Med Assoc J (1979) 1.54
Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol (1986) 1.54
Support for restrictive tobacco policies among residents of selected Minnesota communities. Am J Health Promot (1993) 1.53
Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections. Antimicrob Agents Chemother (1987) 1.53
Severe tetanus: its complications and management. Can Med Assoc J (1965) 1.52
A randomized trial of the impact of risk assessment and feedback on participation in mammography screening. Prev Med (1993) 1.52
HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood (1988) 1.51
Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics (2001) 1.49
Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood (1990) 1.49
Studies of patients in a laminar air flow unit. Cancer (1969) 1.49
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Separation and collection of leukocytes. Cancer Res (1965) 1.45
The organ-cultured cornea: an in vitro study. Invest Ophthalmol (1973) 1.44
Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Cancer Drug Deliv (1983) 1.43
Assessment of community-level influences on individuals' attitudes about cigarette smoking, alcohol use, and consumption of dietary fat. Am J Prev Med (1993) 1.43
Angiogenesis and leukemia. Leuk Res (2001) 1.42
Factors related to length of complete remission in adult acute leukemia. Cancer (1980) 1.42
Onsets of anharmonicity in protein dynamics. Phys Rev Lett (2005) 1.42
Three-dimensional architecture of the cell sheath and septa of Methanospirillum hungatei. J Bacteriol (1985) 1.40
Immunomorphological features of prognostic significance in Dukes' Class B colorectal carcinoma. Cancer Res (1977) 1.40
The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer. J Natl Cancer Inst (1977) 1.40
Cells capable of colony formation in the peripheral blood of man. Science (1971) 1.40
A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood (1985) 1.39
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med (1971) 1.38
Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol (2000) 1.35
Antigen dose in the human immune response. Dose-relationships in the human immune response to Keyhole limpet hemocyanin. J Lab Clin Med (1971) 1.32
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med (1987) 1.30
Pulmonary complications of acute leukemia. Cancer (1966) 1.30
Immunological characterization of homosexual males. Cancer Res (1983) 1.29
Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer (1971) 1.29
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood (1989) 1.29
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia (2009) 1.28
Studiesof a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results. Cancer (1968) 1.28
Influence of hydration on the dynamics of lysozyme. Biophys J (2006) 1.27
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Long-term second remissions in acute lymphatic leukemia. Cancer (1975) 1.27
Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol (1987) 1.26
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. Cancer Res (1984) 1.23
The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood (1965) 1.23
The ultrastructure of human organ-cultured cornea. I. Endothelium. Arch Ophthalmol (1974) 1.23
Lymphocyte activation: a rapid test to predict allograft rejection. Nature (1970) 1.22
Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia (1989) 1.22